First Manhattan’s Apyx Medical APYX Stock Holding History

First Manhattan’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-14,000	Closed	-$51K	–	1440
2014 Q4	$51K	Hold	14,000	–	–	﹤0.01%	975
2014 Q3	$55K	Hold	14,000	–	–	﹤0.01%	941
2014 Q2	$50K	Buy	+14,000	New	+$56.6K	﹤0.01%	959

Other funds holding APYX

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

GMCM

Gruber & McBaine Capital Management San Francisco, California $369M AUM 12.23% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

First Manhattan's APYX Position: Q1 2015 in Review

First Manhattan sold out of Apyx Medical (APYX) in Q1 2015, closing a stake of 14,000 shares — an estimated $51K sold.

First Manhattan first reported a position in APYX in Q2 2014 and held it in 3 quarters. The position peaked at $55K in Q3 2014. 32 funds tracked by Wall St. Rank hold APYX as of Q1 2015.

First Manhattan reported no remaining Apyx Medical position as of Q1 2015 after selling out during the quarter.
First Manhattan sold 14,000 Apyx Medical shares in Q1 2015, an estimated $51K.
First Manhattan first reported a position in Apyx Medical in Q2 2014 and held it in 3 quarters.
First Manhattan's Apyx Medical position peaked at $55K in Q3 2014.
32 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2015.

Based on First Manhattan's 13F filing for Q1 2015, filed 30 Apr 2015.